Narcolepsy and Pandemic Influenza Vaccination

by | Feb 21, 2022 | IABS NEWS

Narcolepsy and Pandemic Influenza VaccinationWhat we know and what we need to know before the next Pandemic March 26-27, 2018Eurostation II, Place Victor Horta Brussels, Belgium In partnership withFederal Agency for Medicines and Health Products (FAMHP)Vaccine Center...

Quality Requirements for Challenge Agents

by | Feb 21, 2022 | IABS NEWS

Quality Requirements for Challenge Agents October 22, 2019An IABS-EU Meeting Read the Meeting Report  Meeting ObjectivesOne of the proposed tools for faster development of new vaccines is CHIM: Controlled Human Infectious Models. These models can be used for early PoC...

Free IABS Membership

by | Feb 18, 2022 | IABS NEWS

Please enable JavaScript in your browser to complete this form.Dear Autogenous Vaccines participants As part of new IABS policy you are eligible to become for free a new IABS member following your attendance of a the Autogenous Vaccines conference last year. If you...

Interview – Joris Vandeputte

by | Sep 5, 2021 | IABS NEWS

In this short interview, Joris Vandeputte, President of IABS has answered the question “What is IABS?” To learn more about the International Alliance for Biological Standardization – IABS, watch this short video or visit our...
IABS
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.